Biomarkers for Targeted Therapies and Immune Checkpoint Inhibitors in Advanced NSCLC

被引：0
|
作者：
Wang, Jie [1 ]
机构：
[1] Chinese Acad Med Sci, Canc Hosp, Thorac Med Oncol, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Immune checkpoint inhibitors; biomarker; dynamic change; Targeted Therapies;
D O I：
10.1016/j.jtho.2016.11.142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MTE09.01
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [1] Circulating Extracellular Vesicles as Biomarkers for Immune-Checkpoint Inhibitors in Advanced NSCLC
    Signorelli, D.
    Fortunato, O.
    Pontis, F.
    Capizzuto, V.
    Ferri, R.
    Brambilla, M.
    Ferrara, R.
    Proto, C.
    Lo Russo, G.
    Prelaj, A.
    Galli, G.
    De Toma, A.
    Viscardi, G.
    Lobefaro, R.
    Nichetti, F.
    Ganzinelli, M.
    Zilembo, N.
    Colombo, M.
    Sozzi, G.
    Garassino, M. C.
    Jachetti, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S405 - S405
  • [2] Mechanism and potential predictive biomarkers of immune checkpoint inhibitors in NSCLC
    Qu, Jialin
    Jiang, Man
    Wang, Li
    Zhao, Deze
    Qin, Kang
    Wang, Yun
    Tao, Junyan
    Zhang, Xiaochun
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 127
  • [3] Tattoo Reactions Associated with Targeted Therapies and Immune Checkpoint Inhibitors for Advanced Cancers: A Brief Review
    Kluger, Nicolas
    DERMATOLOGY, 2019, 235 (06) : 522 - 524
  • [4] Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanoma
    Jalil, Anum
    Donate, Melissa M.
    Mattei, Jane
    CANCER DRUG RESISTANCE, 2024, 7
  • [5] Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma
    Wirsching, Hans-Georg
    Weller, Michael
    Balabanov, Stefan
    Roth, Patrick
    CANCERS, 2021, 13 (12)
  • [6] Immune Checkpoint Inhibitors in NSCLC
    Johnson, Douglas B.
    Rioth, Matthew J.
    Horn, Leora
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 658 - 669
  • [7] Immune Checkpoint Inhibitors in NSCLC
    Douglas B. Johnson
    Matthew J. Rioth
    Leora Horn
    Current Treatment Options in Oncology, 2014, 15 : 658 - 669
  • [8] Immune Checkpoint Inhibitors in Lung Cancer: Role of Biomarkers and Combination Therapies
    Maung, Tun Zan
    Ergin, Huseyin Ekin
    Javed, Mehwish
    Inga, Evelyn E.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [9] Drug eruptions with novel targeted therapies - immune checkpoint and EGFR inhibitors
    Pospischil, Isabella
    Hoetzenecker, Wolfram
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (11): : 1621 - 1641
  • [10] Shining light on advanced NSCLC in 2017: combining immune checkpoint inhibitors
    Qiao, Meng
    Jiang, Tao
    Zhou, Caicun
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1534 - S1546
12345